Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients (Q53969780)

23 May 2018

title

Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients (English)

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(97)80131-2

6 November 2024

0 references

1 reference

1 reference

2

Koletar SL

1 reference

23 May 2018

author name string

P. A. Murray

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220211

6 November 2024

I. Mallegol

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220211

6 November 2024

J. Wu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220211

6 November 2024

B. L. Moskovitz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220211

6 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9220211

6 November 2024

publication date

1 May 1997

1 reference

23 May 2018

May 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9220211

full work available at URL

6 November 2024

https://api.elsevier.com/content/article/PII:S0149291897801312?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(97)80131-2

https://api.elsevier.com/content/article/PII:S0149291897801312?httpAccept=text/plain

6 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(97)80131-2

6 November 2024

published in

Clinical Therapeutics

1 reference

23 May 2018

volume

19

1 reference

23 May 2018

issue

3

1 reference

23 May 2018

page(s)

471-480

1 reference

23 May 2018

Treatment of oropharyngeal candidiasis in HIV-positive patients.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Itraconazole in Antifungal Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Fluconazole-resistant Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Resistance of Candida species to fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Treatment of oral candidosis with itraconazole: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Pharmacokinetics of itraconazole following oral administration to normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Effect of cyclodextrin on the pharmacology of antifungal oral azoles

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980131-2

7 January 2021

Identifiers

1 reference

23 May 2018

1 reference

23 May 2018